Abstract:AbstractBackgroundAlzheimer disease (AD) and traumatic brain injury (TBI) are two devastating brain disorders with complex relationships. Growing evidence supports that early or middle life of TBI may be a risk factor for developing late‐life AD and AD‐related dementias (ADRD). Tau hyperphosphorylation and gliosis may serve as a causative link between TBI and AD as well as ADRD. We have recently identified BCL2 associated athanogene 3 (BAG3) as a hub gene of regulating tau protein homeostasis. The protein level of BAG3 is significantly reduced in neurons, but it is increased in astrocytes of human AD compared to controls. We hypothesized that overexpression of BAG3 in neurons would attenuate tau hyperphosphorylation and gliosis induced by TBI.MethodWe injected 500 nL AAV9‐hSYN1‐eGFP‐2A‐hBAG3‐WPRE or AAV9‐hSYN1‐eGFP‐WPRE (control AAV9) into the hippocampal CA1 and DG regions of C57BL6/J and htau knock‐in mice. These mice were subjected to TBI surgery (controlled cortical impact, velocity: 3.00 m/s, depth: 0.8 mm, dwell time: 200 ms) three months post the injection. We then performed behavioral tests (open‐field test, Y‐maze, and Morris Water Maze) on these mice one month after the CCI surgery. Following the behavioral tests, we collected the brain tissues and performed the immunofluorescent staining of ptau (PHF1, pS396/404 tau), BAG3, IBA‐1 (microglia/macrophage marker) and GFAP (astrocyte marker) on fixed mouse brain floating sections.ResultTBI increased the immunoreactivity of PHF1, IBA‐1, GFAP and astrocytic BAG3, whereas reducing neuronal BAG3 compared to sham C57BL6/J and htau knock‐in mice. Furthermore, the immunoreactivity of BAG3 increased, while PHF1, IBA‐1 and GFAP decreased in the ipsilateral hippocampus after the injection of AAV9‐BAG3 compared to those TBI mice injected with control AAVs. Continued immunofluorescent staining and quantification for AAV9‐BAG3‐ and control AAV9‐injected mice is currently ongoing, as is behavior data quantification.ConclusionTBI induces tau hyperphosphorylation, microglia activation and reactive astrocytes, while reducing neuronal BAG3 in C57BL6/J and htau knock‐in mice. Neuronal overexpression of BAG3 can significantly attenuate tau hyperphosphorylation and gliosis induced by TBI. Our data suggests that targeting neuronal BAG3 may be a therapeutic strategy for preventing or reducing intra‐neuronal tau aggregates and gliosis found in TBI and TBI‐associated AD and ADRD.

A role of BAG3 in regulating SNCA/α-synuclein clearance via selective macroautophagy.

A Role of BAG3 in Regulating SNCA/α-synuclein Clearance Via Selective Macroautophagy

BAG3 Promotes Autophagy and Suppresses NLRP3 Inflammasome Activation in Parkinson's Disease.

BAG3 regulates RAB35 mediates the Endosomal Sorting Complexes Required for Transport/Endolysosome pathway and Tau clearance

BAG3 Regulation of Rab35 Mediates the Endosomal Sorting Complexes Required for Transport /endolysosome Pathway and Tau Clearance

BAG3 regulates the specificity of the recognition of specific MAPT species by NBR1 and SQSTM1

BAG3 and SYNPO (synaptopodin) facilitate phospho-MAPT/Tau degradation via autophagy in neuronal processes.

The BAG2 and BAG5 Proteins Inhibit the Ubiquitination of Pathogenic Ataxin3-80Q.

The Role of the Multifunctional BAG3 Protein in Cellular Protein Quality Control and in Disease

BAG3 promotes autophagy and glutaminolysis via stabilizing glutaminase

Co‐chaperone BAG3 enters autophagic pathway via its interaction with microtubule associated protein 1 light chain 3 beta

BAG3 Overexpression Attenuates Ischemic Stroke Injury by Activating Autophagy and Inhibiting Apoptosis

BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62

Cyclin-Dependent Kinase 5-Dependent BAG3 Degradation Modulates Synaptic Protein Turnover

Suppression of Astrocytic Autophagy by Αb-Crystallin Contributes to Α-Synuclein Inclusion Formation

Bcl2-associated Athanogene 3 Interactome Analysis Reveals a New Role in Modulating Proteasome Activity

MANF Inhibits Α-Synuclein Accumulation Through Activation of Autophagic Pathways

Crosstalk Between the Proteasome System and Autophagy in the Clearance of Α-Synuclein

BAG3 attenuates tau hyperphosphorylation and gliosis induced by traumatic brain injury

Expression of Mutant but Not Wild-Type Α-Synuclein in SH-SY5Y Cells Induces Apoptosis and Autophagy: Implication for Regulation of Cell Death in Parkinson's Disease

Commentary: BAG3 as a Mediator of Endosome Function and Tau Clearance